April 12, 2019
Sumitomo Dainippon President Hiroshi Nomura Sumitomo Dainippon Pharma unveiled its new five-year business plan on April 11, setting out a sales target of 600 billion yen in FY2022 through March 2023, some 140 billion yen higher than the 466.8 billion...read more